Latest Articles
Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial - Nature
Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial Nature
Published: Aug. 26, 2025, 11:43 a.m.
GSK Launches Jemperli for Advanced Endometrial Cancer and Zejula for Ovarian Cancer in India - geneonline.com
GSK Launches Jemperli for Advanced Endometrial Cancer and Zejula for Ovarian Cancer in India geneonline.com
Published: Aug. 25, 2025, 12:03 p.m.
AstraZeneca’s DESTINY-Endometrial01: A New Frontier in Endometrial Cancer Treatment - TipRanks
AstraZeneca’s DESTINY-Endometrial01: A New Frontier in Endometrial Cancer Treatment TipRanks
Published: Aug. 24, 2025, 4:50 p.m.
5 Subtle Signs of Endometrial Cancer You Should Never Ignore, According to Doctors - aol.com
5 Subtle Signs of Endometrial Cancer You Should Never Ignore, According to Doctors aol.com
Published: Aug. 23, 2025, 9:57 p.m.
AstraZeneca’s DESTINY-Endometrial01 Study: A New Horizon in Endometrial Cancer Treatment - TipRanks
AstraZeneca’s DESTINY-Endometrial01 Study: A New Horizon in Endometrial Cancer Treatment TipRanks
Published: Aug. 23, 2025, 6:45 a.m.
Surgical Outcomes of Open, Laparoscopic, and Robotic-Assisted Approaches for Stage I Endometrial Cancer: Insights From a Real-World Study by the Indian Gynecologic-Onco Study Group - Cureus
Surgical Outcomes of Open, Laparoscopic, and Robotic-Assisted Approaches for Stage I Endometrial Cancer: Insights From a Real-World Study by the Indian Gynecologic-Onco Study Group Cureus
Published: Aug. 23, 2025, 6:05 a.m.
Cumulative abdominal obesity exposure and progressive risk of endometrial cancer in young women: a nationwide cohort study - Nature
Cumulative abdominal obesity exposure and progressive risk of endometrial cancer in young women: a nationwide cohort study Nature
Published: Aug. 22, 2025, 6:50 p.m.
BioNTech’s Promising Phase III Study in Recurrent Endometrial Cancer - TipRanks
BioNTech’s Promising Phase III Study in Recurrent Endometrial Cancer TipRanks
Published: Aug. 22, 2025, 4:17 p.m.
NIH Grants Funding to Investigate Socio-Genomic Influences on Local Endometrial Cancer Survival Rates - BIOENGINEER.ORG
NIH Grants Funding to Investigate Socio-Genomic Influences on Local Endometrial Cancer Survival Rates BIOENGINEER.ORG
Published: Aug. 22, 2025, 3:41 a.m.
NIH award to explore socio-genomic factors of local endometrial cancer survival rates - EurekAlert!
NIH award to explore socio-genomic factors of local endometrial cancer survival rates EurekAlert!
Published: Aug. 21, 2025, 4:11 p.m.
Link copied to clipboard!